Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in Germline BRCA-mutated HER2-negative Breast Cancer
View Full LandscapeTarget Indication
Germline BRCA-mutated HER2-negative Breast Cancer
Clinical Trial
NCT05576389Last updated: 8/15/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Non-Small-Cell Lung Cancer
Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer
Primary Hypercholesterolemia
HER2-positive Breast Cancer
Severe Aplastic Anemia